Steven Vold, MD
Glaucoma Specialist · Winter Garden, FLNPI 1891757399
Payments from drug & device makers
Across 765 payments — averaging $3221.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Glaukos Corporation$545K
- Rxsight Inc$444K
- Sight Sciences, Inc.$400K
- AbbVie$365K
- Alcon Research LLC$248K
- Carl Zeiss Meditec, Inc.$181K
- plus $282K from 21 others
Across 92 payments — averaging $5926.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Carl Zeiss Meditec, Inc.$272K
- Bausch Health US, LLC$140K
- Rxsight Inc$70K
- NEW World Medical,inc.$64K
- AbbVie$5
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Glaukos Corporation | 203 | $545,106 |
| Rxsight Inc | 127 | $443,775 |
| Sight Sciences, Inc. | 59 | $399,789 |
| AbbVie(2 entities) | 151 | $364,624 |
| Alcon Research LLC | 19 | $248,473 |
| Carl Zeiss Meditec, Inc. | 38 | $181,249 |
| Alcon | 35 | $62,266 |
| Carl Zeiss Meditec Production LLC | 4 | $58,080 |
| Ivantis, Inc | 15 | $53,620 |
| Bausch Health US, LLC | 9 | $50,719 |
| Bausch & Lomb Americas Inc. | 6 | $20,446 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 24 | $16,917 |
| Carl Zeiss Meditec USA, Inc. | 31 | $13,958 |
| Carl Zeiss Meditec AG | 2 | $3,269 |
| Aerie Pharmaceuticals, Inc. | 8 | $770 |
| Harrow Eye, LLC | 4 | $380 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $359 |
| Beaver-visitec International, Inc. | 1 | $216 |
| Dompe US, Inc. | 2 | $153 |
| NEW World Medical,inc. | 1 | $144 |
| Amgen(2 entities) | 8 | $140 |
| Lensar, Inc. | 4 | $70 |
| Biotissue Holdings Inc. | 2 | $30 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $16 |
| Ocular Therapeutix, Inc. | 1 | $15 |
| Novartis | 1 | $13 |
How this compares
$2,464,616 in reported general payments places this provider in the 95th percentile of 31 glaucoma specialist providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other glaucoma specialist in Winter Garden
- Analisa ArosemenaMiami Beach$438K
- Matthew BrinkPalm Beach Gardens$159K
- Yue WangMelbourne$92K
- David GreenfieldMiami$32K
- Mark WernerDelray Beach$24K
- Dan ArreazaHialeah$9K
- Daniel JewelewiczDelray Beach$9K
- Joah AliancyPort Orange$7K
- Phil AlabataCrestview$7K
- Clinton SheetsHudson$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.